Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company targeting to revolutionize life-science product development.
INVESTOR RELATIONS CONTACT
Upcoming events
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2022
May 10, 2022
More info